Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
The Best Games On the planet- Experience Sports in Dubai: A Daredevil's Aide
- Which game do you cherish observing live? Vote!
- The Most Notable Design Brands of the 21st Hundred years
- Novartis to build manufacturing hub in North Carolina, creating 700 jobs
- The most effective method to Refresh the Infotainment Framework in the Volvo XC40
- This Unique National Park In Canada Is Famous For Its Otherworldly Limestone Monoliths
- 6 Famous kind of practice on the planet
- Soldiers seize power in Guinea-Bissau and detain the president
